National Institute on Drug Abuse (NIDA): all 393 studies

Page 1 of 4. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Olfactory Function and Model-Based Behavior in People Living With HIV and SUDRecruitingNCT07637669
• Trial of Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07468552Phase 2
• Phase 1 Study of Oral MG001Not yet recruitingNCT07204171Phase 1
• Causal Mechanisms of Odor-Guided Behavior in HumansNot yet recruitingNCT07099092Early Phase 1
• Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of FentanylEnrolling by invitationNCT06995885
• Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)Not yet recruitingNCT06868914Phase 1
• Environment and Alcohol: A Pilot StudyRecruitingNCT06860607Phase 1
• VK4-116 Phase I Study With Food-EffectNot yet recruitingNCT06808932Phase 1
• SMART-r: Substance Monitoring and Active Relapse Tracking RepositoryRecruitingNCT06676059
• Developing Transcranial Neuromodulation Protocols for Learning and Decision-MakingRecruitingNCT06561828Early Phase 1
• Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRPRecruitingNCT06552741
• Spironolactone in Alcohol Use Disorder (SAUD)RecruitingNCT05807139Phase 1
• Development and Validation of Learning and Decision-Making TasksRecruitingNCT05707806
• Orexin s Role in the Neurobiology of Substance Use DisorderRecruitingNCT05630781Not applicable
• Defining Neurobiological Links Between Substance Use and Mental IllnessRecruitingNCT05538910Not applicable
• Evaluation of the Interactions of Cannabidiol (CBD) With MorphineRecruitingNCT05143424Phase 1
• Outcome Inference in the Sensory Preconditioning Task in Opioid-Use DisorderRecruitingNCT03745339
• Mechanism of Non-invasive Magnetic StimulationRecruitingNCT03394066Not applicable
• Advanced Functional and Structural MRI Techniques for Neuropharmacological ImagingRecruitingNCT01036581Not applicable
• Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot StudyTerminatedNCT06503159Not applicableResults posted
• SXC-2023 Cocaine Interaction StudyCompletedNCT06343532Phase 1Results posted
• Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUDTerminatedNCT04316559Phase 2Results posted
• Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use DisorderCompletedNCT03896516Phase 1/2Results posted
• Just-In-Time Adaptive Interventions for Addictive BehaviorsTerminatedNCT03538652Not applicableResults posted
• Lorcaserin in the Treatment of Cocaine Use DisorderCompletedNCT03007394Phase 2Results posted
• Theta-Burst Stimulation as a Treatment for Reducing Cocaine UseTerminatedNCT02927236Not applicableResults posted
• Effects of a New Behavioral Intervention on Alcohol Craving and DrinkingCompletedNCT02831049Not applicableResults posted
• The Study of AZD8529 for Smoking Cessation in Female SmokersCompletedNCT02401022Phase 2Results posted
• Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot StudyCompletedNCT02231892Not applicableResults posted
• Laboratory Study of Cannabidiol on the Effects of Smoked MarijuanaCompletedNCT01844687Phase 2Results posted
• Three Strategies for Implementing Motivational Interviewing on Medical Inpatient UnitsCompletedNCT01825057Not applicableResults posted
• A Multi-Center Trial of Nepicastat for Cocaine DependenceCompletedNCT01704196Phase 2Results posted
• Nicotine Withdrawal Symptoms and Smoking RelapseCompletedNCT01511614Not applicableResults posted
• Oxytocin and Cognitive Behavioral Therapy in Drug DependenceTerminatedNCT00975416Phase 4Results posted
• Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine DependenceCompletedNCT00687713Phase 2Results posted
• Phase 2, Multi-Center Trial of Modafinil for Methamphetamine DependenceCompletedNCT00520286Phase 2Results posted
• The Discriminative Effects of Tramadol in HumansCompletedNCT00499746Phase 1/2Results posted
• Ph1 Marinol Interaction Study - Part 2 - 1CompletedNCT00490269Phase 1Results posted
• Selegiline for Smoking Cessation - 1CompletedNCT00439413Phase 2Results posted
• Topiramate for the Treatment of Methamphetamine Dependence - 1CompletedNCT00345371Phase 2Results posted
• Effectiveness of Bupropion for Smokers Recovering From Alcohol DependenceCompletedNCT00304707Phase 3Results posted
• Effectiveness of Bupropion for Treating Nicotine Dependence in Young PeopleCompletedNCT00129272Phase 2Results posted
• Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use DisorderSuspendedNCT06577454Not applicable
• Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use DisorderActive, not recruitingNCT06233799Phase 3
• Semaglutide Therapy for Alcohol Reduction (STAR)Active, not recruitingNCT06015893Phase 2
• Adolescent Vaping Characterization and Parent Views on Adolescent Vaping ProtocolTerminatedNCT05669716
• Real-world Momentary Assessment of Kratom Use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom Use and PharmacologyCompletedNCT05457803
• Evaluation of Intranasal Naltrexone and NaloxoneCompletedNCT03851731Phase 1
• State and Trait Mediated Response to TMS in Substance Use DisorderWithdrawnNCT03707600Not applicable
• Imaging Biomarker for Addiction Treatment OutcomeTerminatedNCT03427424
• Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and AlprazolamCompletedNCT03398083Phase 1
• Comparison of Naloxone PharmacokineticsCompletedNCT03386591Phase 1
• Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot StudyCompletedNCT03152760
• Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy VolunteersCompletedNCT03129347Phase 1
• Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy VolunteersCompletedNCT02750748Phase 1
• Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy VolunteersCompletedNCT02572089Phase 1
• Study to Assess Potential Interactions Between Intravenous Cocaine and Oral LorcaserinCompletedNCT02393599Phase 1
• Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African AmericansCompletedNCT02225184
• Effects of Cannabis Administration Routes on Human Performance and PharmacokineticsCompletedNCT02177513Phase 1
• Multi-Level HIV Prevention for Pregnant Drug AbusersCompletedNCT01976702Not applicable
• Brain Networks and Addiction SusceptibilityCompletedNCT01924468Phase 1
• Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverityCompletedNCT01867411
• Tobacco Cessation: Treatment Delivery and Predictors of OutcomeWithdrawnNCT01859364
• Interactions Between Intravenous Cocaine and Acetazolamide or QuinineCompletedNCT01851473Phase 1
• Factors Affecting Methamphetamine and Opiates Drug TestingCompletedNCT01736332Phase 1
• Individual and Group Intervention Formats With Aggressive ChildrenCompletedNCT01710969Not applicable
• Studying Nicotine Addiction With Transcranial Magnetic StimulationCompletedNCT01702948
• Understanding Drug Abuse Treatment OutcomesCompletedNCT01678833
• Pexacerfont for Stress-induced Food CravingTerminatedNCT01656577Early Phase 1
• Individual Differences in Reward and Impulse ControlCompletedNCT01621607
• Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal SymptomsCompletedNCT01603992
• Evaluating Alternative Aftercare Models for Ex-offendersCompletedNCT01586689Phase 2
• Effectiveness of Motivational Interviewing Supervision in Community ProgramsCompletedNCT01586676Phase 2/3
• Health Outcomes by Neighborhood - BaltimoreCompletedNCT01571752
• Pexacerfont to Reduce Stress-induced Tobacco CravingWithdrawnNCT01557556
• Stem Cell Study of Genetics and Drug AddictionCompletedNCT01534624
• Pioglitazone to Treat Opioid Withdrawal SymptomsTerminatedNCT01517165Phase 1
• Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic PolymorphismsCompletedNCT01505725
• Teenagers, Drug Addiction, and Reward and Impulse ControlWithdrawnNCT01443949
• Brain Functions Underlying Visuospatial Attention Deficits in SchizophreniaCompletedNCT01399437
• Brain Circuits in Schizophrenia and SmokingCompletedNCT01369966
• Neutral Correlates of Risk-taking in Adolescents Exposed to Drugs PrenatallyCompletedNCT01365988
• Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction StudyCompletedNCT01359930Phase 1
• Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive ImpairmentWithdrawnNCT01309685Phase 1
• Nicotinic Receptor Density in Smoking and Nonsmoking SchizophrenicsWithdrawnNCT01246128
• Nicotinic Modulation of the Default Network of Resting Brain FunctionCompletedNCT01240616
• Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy PatientsCompletedNCT01229163Early Phase 1
• Pilot Study of Repetitive Transcranial Magnetic Stimulation in Cocaine CravingWithdrawnNCT01222806Phase 1
• Effects of Antipsychotics on Eating and Food Craving in People With SchizophreniaCompletedNCT01222793
• Assessment of Cannabis Craving in Schizophrenia Using Virtual RealityCompletedNCT01212081
• Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco DependenceCompletedNCT01208935Phase 2/3
• Reinforcement-Based Treatment for Pregnant Drug AbusersCompletedNCT01177982Phase 2/3
• Interactions Between Intravenous (IV) Cocaine and LofexidineTerminatedNCT01148992Phase 1
• Characterization of Phenotypic and Genotypic Regressors for ImagingCompletedNCT01148381
• Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Adolescent SmokersCompletedNCT01148355
• Neurobiology and Pharmacokinets of Acute MDMA AdministrationCompletedNCT01148342Phase 1
• Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal SprayCompletedNCT01136642Phase 1
• Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked CannabisCompletedNCT01071616Phase 1
• The Neural Basis of Cue-Elicited Cigarette Craving and Its ControlCompletedNCT01048957Not applicable
• Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy AdultsCompletedNCT01046539Phase 1

← National Institute on Drug Abuse (NIDA) overview and focus areas